Angela Maria Acquaviva

Angela Maria Acquaviva

Auto-generated profile, based on publicly available information

Angela Maria Acquaviva

Department of Biology and Cellular and Molecular Pathology ‘L. Califano’, University of Naples Federico II, Naples, Italy

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MRMarco Romano
Marco Romano
VRVittorio Ricci
Vittorio Ricci
AMAnnamaria Memoli
Annamaria Memoli
CTConcetta Tuccillo
Concetta Tuccillo
APAnna Di Popolo
Anna Di Popolo
Raffaele ZarrilliRaffaele Zarrilli
Raffaele Zarrilli
Helicobacter pylori has been suggested to play a role in the development of gastric carcinoma in humans. Also, mounting evidence indicates that cyclooxygenase-2 overexpression is associated with gastrointestinal carcinogenesis. We studied the effect of H. pylori on the expression and activity of cyclooxygenase-1 and cyclooxygenase-2 in MKN 28 gastric mucosal cells. H. pylori did not affect cyclooxygenase-1 expression, whereas cyclooxygenase-2 mRNA levels increased by 5-fold at 24 h after incubation of MKN 28 cells with broth culture filtrates or bacterial suspensions from wild-type H. pyloristrain. Also, H. pylori caused a 3-fold increase in the release of prostaglandin E2, the main product of cyclooxygenase activity. This effect was specifically related toH. pylori because it was not observed withEscherichia coli and was independent of VacA, CagA, or ammonia. H. pylori isogenic mutants specifically lackingpicA or picB, which are responsible for cytokine production by gastric cells, were less effective in the up-regulation of cyclooxygenase-2 mRNA expression and in the stimulation of prostaglandin E2 release compared with the parental wild-type strain. This study suggests that development of gastric carcinoma associated with H. pylori infection may depend on the activation of cyclooxygenase-2-related events.

18 March 2003 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
PRP Ricchi
P Ricchi
Raffaele ZarrilliRaffaele Zarrilli
Raffaele Zarrilli
APA di Palma
A di Palma
AAA M Acquaviva
A M Acquaviva
In this review, we discuss the available experimental evidences supporting the chemopreventive efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) on colorectal cancer and the biological basis for their possible role as anticancer agents. Although the comprehension of the mechanisms underlying the effects of these drugs on colon cancer cells is incomplete, research efforts in identifying the biochemical pathway by which NSAIDs exert their chemopreventive effect have provided a rationale for the potential use of NSAIDs alone or in combination with conventional and experimental anticancer agents in the treatment of colorectal cancer. In this paper, we review three main issues: (i) the role of COX-2 in colon cancer; (ii) the common death pathways between NSAIDs and anticancer drugs; and (iii) the biological basis for the combination therapy with COX-2 selective inhibitors and new selective inhibitors of growth factor signal transduction pathways.

16 November 2000 in Oncogene
Verified
Journal Article
Closed access
PDF file
APAnna Di Popolo
Anna Di Popolo
AMAnnamaria Memoli
Annamaria Memoli
AAAnna Apicella
Anna Apicella
CTConcetta Tuccillo
Concetta Tuccillo
APAntonella di Palma
Antonella di Palma
Raffaele ZarrilliRaffaele Zarrilli
Raffaele Zarrilli

1 October 2007 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
PDF file
VLVincenza Leone
Vincenza Leone
APAntonella di Palma
Antonella di Palma
PRPaolo Ricchi
Paolo Ricchi
FAFabio Acquaviva
Fabio Acquaviva
MGMaria Giannouli
Maria Giannouli
AAAngela M. Acquaviva
Angela M. Acquaviva
PGE2plays a critical role in colorectal carcinogenesis. We have previously shown that COX-2 expression and PGE2synthesis are mediated by IGF-II/IGF-I receptor signaling in the Caco-2 cell line and that the pathway of phosphatidylinositol 3-kinase (PI3K)/Akt protects the cell from apoptosis. In the present study, we demonstrate that PGE2has the ability to increase Ras and PI3K association and decrease the level of apoptosis in the same experimental system. The effect of PGE2on PI3K/Ras association is dependent on the activation of EP4 receptor, the increase of cAMP levels, and the activation of PKA. In fact, treatment of cells with the PKA inhibitor H89 decreases the association of Ras and PI3K and Ras-associated PI3K activity. PKA inhibitor H89 is able to decrease threonine phosphorylation of Akt and to increase serine phosphorylation of Akt by p38 MAPK and counteracts the cytoprotective effect induced by PGE2. In addition, PGE2is able to activate p38 MAPK and the inhibition of p38 MAPK, with SB203580 specific inhibitor or with dominant negative MKK6 kinase, is able to revert the apoptotic effect of H89 and serine phosphorylation of Akt. The effect of PGE2on Caco-2 cell survival through PKA activation is mediated and regulated by the balance of threonine/serine phosphorylation of Akt by p38 kinase and PI3K. In conclusion, our data elucidate a novel mechanism for regulation of colon cancer cell survival and provide evidences for new combinatory treatments of colon cancer.

11 December 2004 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
AOAlessandro Ottaiano
Alessandro Ottaiano
APAntonella di Palma
Antonella di Palma
MNMaria Napolitano
Maria Napolitano
CPCarmen Pisano
Carmen Pisano
SPSandro Pignata
Sandro Pignata
Stefania ScalaStefania Scala
Stefania Scala

1 July 2010 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
GAGabriella Aviello
Gabriella Aviello
IRIan Rowland
Ian Rowland
CGChristopher I. Gill
Christopher I. Gill
AAAngela Maria Acquaviva
Angela Maria Acquaviva
FCFrancesco Capasso
Francesco Capasso
Francesca BorrelliFrancesca Borrelli
Francesca Borrelli
In recent years, the use of anthraquinone laxatives, in particular senna, has been associated with damage to the intestinal epithelial layer and an increased risk of developing colorectal cancer. In this study, we evaluated the cytotoxicity of rhein, the active metabolite of senna, on human colon adenocarcinoma cells (Caco‐2) and its effect on cell proliferation. Cytotoxicity studies were performed using 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT), neutral red (NR) and trans‐epithelial electrical resistance (TEER) assays whereas 3H‐thymidine incorporation and Western blot analysis were used to evaluate the effect of rhein on cell proliferation. Moreover, for genoprotection studies Comet assay and oxidative biomarkers measurement (malondialdehyde and reactive oxygen species) were used. Rhein (0.1–10 μg/ml) had no significant cytotoxic effect on proliferating and differentiated Caco‐2 cells. Rhein (0.1 and 1 μg/ml) significantly reduced cell proliferation as well as mitogen‐activated protein (MAP) kinase activation; by contrast, at high concentration (10 μg/ml) rhein significantly increased cell proliferation and extracellular‐signal‐related kinase (ERK) phosphorylation. Moreover, rhein (0.1–10 μg/ml): (i) did not adversely affect the integrity of tight junctions and hence epithelial barrier function; (ii) did not induce DNA damage, rather it was able to reduce H2O2‐induced DNA damage and (iii) significantly inhibited the increase in malondialdehyde and reactive oxygen species (ROS) levels induced by H2O2/Fe2+. Rhein was devoid of cytotoxic and genotoxic effects in colon adenocarcinoma cells. Moreover, at concentrations present in the colon after a human therapeutic dosage of senna, rhein inhibited cell proliferation via a mechanism that seems to involve directly the MAP kinase pathway. Finally, rhein prevents the DNA damage probably via an anti‐oxidant mechanism.